Atossa Therapeutics
ATOS
#9420
Rank
NZ$0.14 B
Marketcap
NZ$1.13
Share price
1.36%
Change (1 day)
-31.50%
Change (1 year)

Earnings for Atossa Therapeutics (ATOS)

Earnings in 2025 (TTM): -NZ$51.93 Million

According to Atossa Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -NZ$44.18 Million, an increase over its 2023 earnings that were of -NZ$52.12 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atossa Therapeutics from 2011 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$51.93 Million17.55%
2024 -NZ$44.18 Million-15.25%
2023 -NZ$52.12 Million11.62%
2022 -NZ$46.7 Million30.84%
2021 -NZ$35.69 Million15.58%
2020 -NZ$30.88 Million3.41%
2019 -NZ$29.86 Million51.16%
2018 -NZ$19.76 Million40.41%
2017 -NZ$14.07 Million27.54%
2016 -NZ$11.04 Million-47.49%
2015 -NZ$21.01 Million-17.25%
2014 -NZ$25.39 Million35.91%
2013 -NZ$18.68 Million112.3%
2012 -NZ$8.8 Million46.53%
2011 -NZ$6.01 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$56.10 B-107,442.61%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$2.30 B-4,517.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
NZ$2.22 B-4,364.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-NZ$13.58 Million-74.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
NZ$72.18 M-238.11%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-NZ$0.19 Billion 261.87%๐Ÿ‡บ๐Ÿ‡ธ USA